Conformationally constrained analogues of diacylglycerol .11. Ultrapotent protein kinase C ligands based on a chiral 5-disubstituted tetrahydro-2-furanone template

被引:40
作者
Lee, J
Wang, SM
Milne, GWA
Sharma, R
Lewin, NE
Blumberg, PM
Marquez, VE
机构
[1] NCI,MED CHEM LAB,DEV THERAPEUT PROGRAM,DIV CANC TREATMENT,BETHESDA,MD 20892
[2] NCI,CELLULAR CARCINOGENESIS & TUMOR PROMOT LAB,MOLEC MECH TUMOR PROMOT SECT,BETHESDA,MD 20892
关键词
D O I
10.1021/jm950277n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Conformationally constrained analogues of diacylglycerol (DAG) built on a racemic-5-[(acyloxy)methyl]-5-(hydroxymethyl)tetrahydro-2-furanone template template were shown previously to have excellent binding affinities for protein kinase C (PK-C). Since the interaction of PK-C with DAG is stereospecific, it was anticipated that PK-C would bind tightly to only one enantiomeric form of the compounds constructed with this new lactone template. Separation of enantiomers by chiral HPLC was discarded due to the ease with which acyl migration occurs in these class of compounds, and a total chiral synthesis was undertaken. Prior to chemical synthesis, the selection of the ''correct'' enantiomeric template was predicted by a molecular conformational analysis that compared the two enantiomers of DAG in their presumed ''active'' conformation with the two enantiomeric lactone templates. This presumed ''active'' conformation for DAG was derived from a previously developed pharmacophore model that uses the molecule of a potent phorbol diester as the ideal rigid template. The results from this analysis indicated that the ''correct'' lactone template corresponded to the inactive (R)-isomer of DAG. This analysis also predicted that the lactone template corresponding to the active (S)-DAG enantiomer would not fit adequately into the pharmacophore. The chiral syntheses of target compounds 2, 4, and 6, constructed on the selected, and presumably ''correct'' lactone template, were achieved from a common bicyclic intermediate (5R,8R,9R)-8,9-O-isopropylidene-2-keto-1,7-dioxaspiro[4.4]nonane (10) that was synthesized from commercially available 1,2:3,5-di-O-isopropylidene-alpha-D-threo-apiofuranose (7) by a very effective spirolactonization approach. On the basis of their ability to inhibit the binding of [H-3-20]phorbol 12,13-dibutyrate (PDBU) to PK-C alpha, the enantiomeric ligands 2, 4, and 6 were twice as potent as the corresponding racemates. These results confirm that binding of these lactones is stereospecific and consistent with a binding mechanism similar to that of DAG.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 14 条
  • [1] CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTER - COMPUTER-BASED SEARCH, RETRIEVAL, ANALYSIS AND DISPLAY OF INFORMATION
    ALLEN, FH
    BELLARD, S
    BRICE, MD
    CARTWRIGHT, BA
    DOUBLEDAY, A
    HIGGS, H
    HUMMELINK, T
    HUMMELINKPETERS, BG
    KENNARD, O
    MOTHERWELL, WDS
    RODGERS, JR
    WATSON, DG
    [J]. ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1979, 35 (OCT): : 2331 - 2339
  • [2] BONI LT, 1985, J BIOL CHEM, V260, P819
  • [3] X-RAY STRUCTURE ANALYSIS OF NEOPHORBOL, C31H3509BR, AND PHORBOL, C20H2806
    BRANDL, F
    ROHRL, M
    ZECHMEIS.K
    HOPPE, W
    [J]. ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL CRYSTALLOGRAPHY AND CRYSTAL CHEMISTRY, 1971, B 27 (SEP15): : 1718 - &
  • [4] CAHIEZ G, 1978, TETRAHEDRON LETT, V19, P3013
  • [5] Carey F. A., 1966, CARBOHYD RES, V3, P205
  • [6] REDUCTIVE COUPLING OF KETONES OR ALDEHYDES WITH ELECTRON-DEFICIENT ALKENES PROMOTED BY SAMARIUM DIIODIDE
    FUKUZAWA, S
    NAKANISHI, A
    FUJINAMI, T
    SAKAI, S
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1986, (08) : 624 - 625
  • [7] GESCHER A, 1989, ANTI-CANCER DRUG DES, V4, P93
  • [8] KAZANIETZ MG, 1993, MOL PHARMACOL, V44, P298
  • [9] LEE J, 1994, SYNLETT, P206
  • [10] THE STEREOSPECIFIC ACTIVATION OF PROTEIN KINASE-C
    RANDO, RR
    YOUNG, N
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 122 (02) : 818 - 823